United States Cellular Corporation USM
77.01 0.00 (+0.00%)
At closeAug 11, 2025, 4:00 PM EDT
74.50 Day range 79.08
9.57 52-week range 79.17
- YTD
- +22.78%
- 1 year
- +48.67%
Analyst view
Consensus: buy
Buy
Price target (mean) 81.25 +5.5% upside
Now 77.01
- Target (low)
- 72.00
- Target (mean)
- 81.25
- Target (high)
- 87.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy2
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.40 | 0.40 – 0.40 | -0.92 | +143.5% | 902.73M | -2.1% | 1 |
| Next quarter | 0.04 | 0.04 – 0.04 | 0.05 | -20.0% | 926.15M | -4.5% | 1 |
| Current year | -11.93 | -11.93 – -11.93 | 0.71 | -1780.3% | 3.34B | -11.5% | 1 |
| Next year | -0.05 | -0.05 – -0.05 | -11.93 | +99.6% | 2.94B | -11.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 25, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| May 28, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| May 5, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| Feb 24, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 7, 2024 | Raymond James | Upgrade | Market Perform | Outperform |
| Nov 4, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| May 30, 2024 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| May 29, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| May 13, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 11, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 9, 2023 | Wells Fargo | Upgrade | Underweight | Equal-Weight |
| Aug 8, 2023 | JP Morgan | Upgrade | Neutral | Overweight |
| Jul 26, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 25, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2023 | Wells Fargo | Maintained | — | Underweight |
| Feb 7, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jan 10, 2023 | Wells Fargo | Downgrade | Overweight | Underweight |
| Nov 8, 2022 | JP Morgan | Upgrade | Underweight | Neutral |
| Nov 7, 2022 | Raymond James | Downgrade | Strong Buy | Market Perform |
| Aug 8, 2022 | Raymond James | Maintained | — | Strong Buy |
| May 9, 2022 | Raymond James | Maintained | — | Strong Buy |
| Apr 19, 2022 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Feb 22, 2022 | Wells Fargo | Maintained | — | Overweight |
| Feb 22, 2022 | Raymond James | Maintained | — | Strong Buy |
| Aug 2, 2021 | JP Morgan | Downgrade | Neutral | Underweight |
| Jul 22, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Feb 22, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Jan 14, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Aug 31, 2020 | Citigroup | Maintained | — | Buy |